These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 28414309)
1. Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment. Nandhu MS; Kwiatkowska A; Bhaskaran V; Hayes J; Hu B; Viapiano MS Oncogene; 2017 Aug; 36(34):4875-4886. PubMed ID: 28414309 [TBL] [Abstract][Full Text] [Related]
2. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells. Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445 [TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling. Cherry EM; Lee DW; Jung JU; Sitcheran R Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756 [TBL] [Abstract][Full Text] [Related]
4. Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling. Kim JK; Jin X; Sohn YW; Jin X; Jeon HY; Kim EJ; Ham SW; Jeon HM; Chang SY; Oh SY; Yin J; Kim SH; Park JB; Nakano I; Kim H Cancer Lett; 2014 Oct; 353(2):194-200. PubMed ID: 25079688 [TBL] [Abstract][Full Text] [Related]
5. TNF-α mediated MEK-ERK signaling in invasion with putative network involving NF-κB and STAT-6: a new perspective in glioma. Ramaswamy P; Goswami K; Dalavaikodihalli Nanjaiah N; Srinivas D; Prasad C Cell Biol Int; 2019 Nov; 43(11):1257-1266. PubMed ID: 30839135 [TBL] [Abstract][Full Text] [Related]
6. Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling. Hu B; Nandhu MS; Sim H; Agudelo-Garcia PA; Saldivar JC; Dolan CE; Mora ME; Nuovo GJ; Cole SE; Viapiano MS Cancer Res; 2012 Aug; 72(15):3873-85. PubMed ID: 22665268 [TBL] [Abstract][Full Text] [Related]
7. Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype. Raychaudhuri B; Han Y; Lu T; Vogelbaum MA J Neurooncol; 2007 Oct; 85(1):39-47. PubMed ID: 17479228 [TBL] [Abstract][Full Text] [Related]
8. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma. Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746 [TBL] [Abstract][Full Text] [Related]
9. FABP5 enhances malignancies of lower-grade gliomas via canonical activation of NF-κB signaling. Wang Y; Wahafu A; Wu W; Xiang J; Huo L; Ma X; Wang N; Liu H; Bai X; Xu D; Xie W; Wang M; Wang J J Cell Mol Med; 2021 May; 25(9):4487-4500. PubMed ID: 33837625 [TBL] [Abstract][Full Text] [Related]
10. Interaction of NF-κB and FOSL1 drives glioma stemness. Ramar V; Guo S; Hudson B; Khedri A; Guo AA; Li J; Liu M Cell Mol Life Sci; 2024 Jun; 81(1):255. PubMed ID: 38856747 [TBL] [Abstract][Full Text] [Related]
11. Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma. Nandhu MS; Behera P; Bhaskaran V; Longo SL; Barrera-Arenas LM; Sengupta S; Rodriguez-Gil DJ; Chiocca EA; Viapiano MS Clin Cancer Res; 2018 Feb; 24(4):821-833. PubMed ID: 29146721 [No Abstract] [Full Text] [Related]
12. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression. Watanabe A; Mabuchi T; Satoh E; Furuya K; Zhang L; Maeda S; Naganuma H J Neurooncol; 2006 Mar; 77(1):25-32. PubMed ID: 16132527 [TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway. Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772 [TBL] [Abstract][Full Text] [Related]
14. Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth. Achyut BR; Angara K; Jain M; Borin TF; Rashid MH; Iskander ASM; Ara R; Kolhe R; Howard S; Venugopal N; Rodriguez PC; Bradford JW; Arbab AS Sci Rep; 2017 Oct; 7(1):13754. PubMed ID: 29062041 [TBL] [Abstract][Full Text] [Related]
15. IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance. Rinkenbaugh AL; Cogswell PC; Calamini B; Dunn DE; Persson AI; Weiss WA; Lo DC; Baldwin AS Oncotarget; 2016 Oct; 7(43):69173-69187. PubMed ID: 27732951 [TBL] [Abstract][Full Text] [Related]
16. Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas. Nandhu MS; Hu B; Cole SE; Erdreich-Epstein A; Rodriguez-Gil DJ; Viapiano MS Cancer Res; 2014 Oct; 74(19):5435-5448. PubMed ID: 25139440 [TBL] [Abstract][Full Text] [Related]
17. CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation. Kuo PL; Shen KH; Hung SH; Hsu YL Carcinogenesis; 2012 Dec; 33(12):2477-87. PubMed ID: 23027620 [TBL] [Abstract][Full Text] [Related]
18. Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis. Gupta P; Dixit D; Sen E Carcinogenesis; 2013 Feb; 34(2):388-96. PubMed ID: 23125226 [TBL] [Abstract][Full Text] [Related]
19. TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance. Loftus JC; Dhruv H; Tuncali S; Kloss J; Yang Z; Schumacher CA; Cao B; Williams BO; Eschbacher JM; Ross JT; Tran NL Mol Cancer Res; 2013 Aug; 11(8):865-74. PubMed ID: 23699535 [TBL] [Abstract][Full Text] [Related]
20. α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development. Wang X; Liu R; Qu X; Yu H; Chu H; Zhang Y; Zhu W; Wu X; Gao H; Tao B; Li W; Liang J; Li G; Yang W Mol Cell; 2019 Oct; 76(1):148-162.e7. PubMed ID: 31447391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]